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Abstract 
Hepatitis C virus (HCV) translation is mediated by an internal ribosome entry site (IRES) located at the 5’ 
end of the genomic RNA. The 3’ untranslatable region (3’UTR) stimulates translation by the recruitment 
of protein factors that simultaneously bind to the 5’ end of the viral genome. This leads to the formation 
of a macromolecular complex with a closed loop conformation, similar to that described for the cap-
translated mRNAs. We previously demonstrated the existence of a long range RNA-RNA interaction 
involving subdomain IIId of the IRES region and the stem-loop 5BSL3.2 of the CRE element at the 3’ 
end of the viral genome. The present study provides evidences that the enhancement of HCV IRES-
dependent translation mediated by the 3’UTR is negatively controlled by the CRE region in the human 
hepatoma cell lines Huh-7 and Hep-G2 in a time-dependent manner. Domain 5BSL3.2 is the major 
partner in this process. Mutations in this motif lead to an increase in IRES activity by up to 8-fold. These 
data support the existence of a functional high order structure in the HCV genome that involves two 
evolutionarily conserved RNA elements, domain IIId in the IRES and stem-loop 5BSL3.2 in the CRE 
region. This interaction could have a role in the circularisation of the viral genome. 
 
Keywords: RNA-RNA interaction; hepatitis C virus (HCV); internal ribosome entry site 
(IRES); cis-acting replication element (CRE); domain 5BSL3.2; domain IIId; IRES-
dependent translation. 
 
Abbreviations:  
HCV, hepatitis C virus; IRES, internal ribosome entry site; UTR, untranslatable region; CRE, cis-acting 
replicating element.   
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INTRODUCTION 
Hepatitis C virus (HCV) infection is the major worldwide cause of post-transfusion non-A, non-B 
hepatitis [1, 2]. Infection frequently leads to cirrhosis and hepatocellular carcinoma [3]. HCV is currently 
the sole member of the Hepacivirus genus, a member of the family Flaviviridae. Its genome is composed 
of a 9.6 kb-long, (+) polarity, single-stranded RNA molecule encoding a single open reading frame (ORF) 
[1, 4, 5]. This is flanked by highly conserved 5’- and 3’- untranslatable regions (5’UTR, 3’UTR), 
extensively folded elements with critical roles in the HCV cycle [6-12]. After virus entry, the genomic 
RNA acts as mRNA to generate a single polyprotein that is co- and post-translationally processed to yield 
structural and non-structural viral proteins. The translation process is initiated by an alternative 
mechanism to cap-dependent translation that requires an internal ribosome entry site (IRES). This 
element is mostly located at the 5’UTR but spans a short stretch of the ORF (Fig. 1a) [13, 14]. The IRES 
operates by the direct recruitment of the 40S ribosomal subunit, governed by specific structural elements 
of the IRES in the absence of initiation factors [15-17]. Both initiation and subsequent elongation steps 
are influenced by the presence of functional domains located at the 3’UTR of the viral RNA [12, 18-22]. 
Though the mechanism by which this stimulation occurs is not fully understood, it has been proposed that 
protein factors might bring together both ends of the viral RNA by simultaneous binding to both regions 
[18, 20, 23-31], thus ensuring the translation of intact molecules [32]. The resulting complex would 
resemble the circular forms of cellular mRNAs that are translated by a cap-dependent mechanism [33, 
34]. As an alternative to this protein bridge formation, RNA elements at the two ends of some viral 
genomes can interact with one another in the absence of protein factors to promote efficient 
circularisation [35, 36]. The acquisition of a closed-loop conformation would be involved not only in the 
regulation of viral translation and replication, but also in the switch between these events.  
We have previously described the existence in HCV genomic RNA of a higher order structure involving 
two evolutionarily well conserved domains [37]: the apical loop of domain IIId in the IRES, and the 
internal loop of 5BSL3.2 in the cis-acting replication element (CRE) region (Fig. 1). Domain IIId is an 
essential element for IRES-mediated translation owing to its direct binding to the 40S ribosomal subunit 
during the initiation step [38-41]. It is composed of two short helixes connected by an E-loop, capped by 
an apical loop (Fig. 1) [42, 43]. Domain 5BSL3.2 is embedded in a tertiary structure composed of three 
stem-loop elements that define the CRE region at the 3’ end of the coding sequence [44, 45]. 5BSL3.2 is 
a structurally indispensable element for replication [44-46]. It is composed of two helical fragments 
connected by an essential internal loop and closed by an apical loop (Fig. 1a). This conformation provides 
an excellent anchoring site for distant RNA regions. In addition to its binding to the IRES region, an 
apical loop-apical loop interaction between 5BSL3.2 and 3’SLII in the 3’UTR occurs [46]. The crosstalk 
established between these functional domains, IIId, 5BSL3.2 and 3’SLII, suggests they have critical roles 
in the switch between essential steps during HCV infection, such as the initiation of translation and 
replication. 
In an effort to elucidate the significance of the long range IIId-5BSL3.2 interaction in the viral cycle, the 
influence of domain 5BSL3.2 in IRES-dependent translation in cell culture was studied. The results 
clearly show that the CRE region downregulates the translation-enhancing effect mediated by the 3’UTR 
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in hepatic cells transfected with chimeric reporter RNAs with different 5’ and 3’ ends. Moreover, the 
HCV CRE by itself drastically blocks HCV IRES-dependent translation. The data suggest that the internal 
loop of domain 5BSL3.2 within the CRE region is an essential participant in this regulation. Indeed, our 
results demonstrate that 5BSL3.2 may be a key modulating agent during HCV initiation of translation, 
and also support the hypothesis of direct RNA-RNA contact between both ends of the viral genome.  
 
MATERIALS AND METHODS 
DNA templates and RNA synthesis 
The DNA template for RLuc RNA was generated as previously described [47]. 
A plasmid containing the ICU reporter construct was obtained as follows. The 5’ end of the HCV genome 
spanning nucleotides 1-698 was obtained by amplification of the plasmid pU5’HCV-691 [48] with 
primers asHCV-698+HindIII and 5’T7pHCV (see Table 1 for oligonucleotide sequences). The 
amplification product was subsequently cloned in the EcoR1 and HindIII restriction sites of the pGL3 
Basic vector (Promega) to yield the construct pGL-I. The 3’ end of the viral genome harbouring residues 
9181-9606 was then added at the 3’ end of the fluc gene. For this, the fragment HCV9181-9606 was 
amplified from plasmid pU3’HCV-9181 [37] with primers HCV-9181+Xba1 and 3’HCV+BamH1, and 
cloned in the restriction sites Xba1 and BamH1 of the pGL-I vector to yield the construct pGL-ICU. The 
oligonucleotide sequences are shown in Table 1. 
Plasmids containing the reporter constructs pGL-IU, pGL-ICUd3.1, pGL-ICUd3.2, pGL-ICUd3.3, pGL-
ICU3.2ALinv, pGL-ICUd3.2dIL, pGL-ICU3.2R and pGL-ICU3.2m were generated by site-directed 
mutagenesis using the Phusion site-directed mutagenesis kit (Finnzymes) from the template vector pGL-
ICU with the following primers: for the pGL-IU, asFLuc and HCV-9383; for the pGL-ICUd3.1, HCV-
9260 and asHCV-9215; for the pGL-ICUd3.2, HCV-9311 and asHCV-9262; for the pGL-ICUd3.3, HCV-
9352 and asHCV-9320; for the pGL-ICU3.2ALinv, HCV-9277ALinv and asHCV-9276; for the pGL-
ICU3.2dIL, HCV-9303 and asHCV-9294; for the pGL-ICU3.2R, HCV-9313 and asHCV-3.2R; and for 
the pGL-ICU3.2m, HCV-9315 and asHCV-3.2mut. A DNA vector encoding the sequence for the reporter 
ICU-d3.1+3.3, pGL-ICU-d3.1+3.3 was obtained by site directed mutagenesis as noted above by 
amplification from the plasmid pGL-ICUd3.1 with the primers HCV-9352 and asHCV-9320.  
Molecules T7pICU, T7pIU, T7pICU-d3.1, T7pICU-d3.2, T7pICU-d3.3, T7pICU-3.2ALinv, T7pICU-
d3.2, T7pICU-d3.2dIL, T7pICU-3.2R and T7pICU-3.2m were amplified from their respective plasmid 
constructs using the primers 5’T7pHCV and 3’HCV to achieve the precise 3’ termini. 
DNA templates encompassing the sequences for the IP and the IC constructs, T7pIP and T7pIC 
respectively, were obtained by PCR from the plasmid pGL-ICU. For the T7pIP molecule, primers 
5’T7pHCV and asFLuc-PolyA were used in the amplification reaction; the T7pIC variant was generated 
with the oligonucleotides 5’T7pHCV and asHCV-9321.  
DNAs encoding the truncated forms of the reporter RNA molecules for the IRES - F, FP, FC, FU, FCU – 
were constructed as follows. The variants F, FC and FCU were obtained by PCR from the vector pGL-
ICU. For the molecule T7pF, primers T7pFLuc and asFLuc were used; the sequence T7pFC was 
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amplified using the oligonucleotides T7pFLuc and asHCV-9321; the construct T7pFCU was generated 
with the primers T7pFLuc and 3’HCV.  
All the RNA molecules used in the transfection assays were obtained as described by Romero-López et 
al. [47]. 
 
Cell lines and culture conditions 
The human hepatoma Huh-7 cells used were a kind gift of Dr. Rafael Aldabe. Cell lines HepG2, HeLa 
and HEK-293 were provided by the Centro de Instrumentación Científica (University of Granada, Spain). 
Cell culture conditions were essentially the same for all cell types. Briefly, cell monolayers were 
maintained in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% heat-inactivated 
foetal bovine serum (Invitrogen) and 1 mM sodium pyruvate (Sigma), at 37ºC in a 5% CO2 atmosphere.  
 
Transfection assays 
Cell transfections were essentially performed as previously described [47]. Briefly, 24 h before 
transfection, 90000 cells were seeded onto a 24-well plate to reach 90% confluency. A mixture containing 
1 μg of the reporter constructs and 0.25 μg of the cap-RLuc was then prepared with 50 μl of Opti-MEM® 
(Invitrogen) and 2 μl of transfection reagent (TransFectinTM, Bio-Rad) for well-to-well normalisation. 
This lipid-RNA complex was added to the cell culture. RNA molecules were denatured prior to 
transfection by heating for 2 min at 95ºC and cooling quickly at 4ºC for 10 min. Translational efficiency 
was determined at the indicated time points by measuring Firefly and Renilla luciferase activities using 
the Dual-Luciferase
TM
 reporter assay system (Promega). 
 
RNA stability assays 
For RNA stability studies, Huh-7 cells were transfected as indicated above. At 6 h and 18 h post-
transfection, the cells were washed with PBS and total cellular RNA was extracted using Trizol reagent as 
previously described [49], following the manufacturer instructions. Relative levels of the reporter 
constructs were detected by quantitative RT-PCR and normalized to that obtained for the reference 
mRNA GAPDH, as reported by Romero-López et al. [49]. PCR was performed using an ABI PRISM 
7000 Sequence Detector System (Applied Biosystems). The results were analysed using ABI PRISM 
7000 SDS software v.1.1 from Applied Biosystems. 
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RESULTS 
The HCV CRE domain inhibits IRES-dependent but not cap-dependent 
translation 
Distant RNA-RNA interactions promote changes in the global RNA conformation that may mediate 
important events for the biology of the host molecule. In an attempt to elucidate the contribution that the 
IRES-CRE connection plays during viral translation, chimeric constructs were designed containing the 
HCV IRES domain fused to the reporter gene fluc encoding the Firefly luciferase protein (named 
molecule I; Fig. 2a). Different 3’ tails were attached to this sequence to evaluate their effect over IRES-
dependent translation: the CRE region to generate the so-called IC construct, and the whole 3’ end 
containing the CRE plus the 3’UTR to yield the ICU variant. To further validate the experimental model, 
two chimeras were generated that increase HCV IRES function: IP, with a polyA tail fused to the 3’ end 
of construct I [19], and IU, composed of molecule I fused to the 3’UTR [12, 18]. The precise 3’ ends of 
these constructs without additional extra sequences were obtained by PCR-generated templates [12], 
which were subsequently transcribed and used for the transfection of the hepatoma cell line Huh-7 along 
with the RNA encoding for the RLuc protein (translated in a cap-dependent manner). Luciferase units 
were measured at 6 h post-transfection at the time of maximum IRES activity [22] and at 18 h.  
Soon after transfection an enhancement in IRES-mediated translation occurred for both the IP and IU 
control constructs. This data strongly agrees with those obtained by other authors, confirming the 
reproducibility of the experimental system [12, 19]. More importantly, a drastic reduction in HCV IRES 
function was observed for the IC construct compared to the I molecule. This effect was suppressed by the 
presence of the 3’UTR in the ICU molecule (Fig. 2b), in which translation was even clearly increased 
with respect to the control RNA I. At 18 h post-transfection, the molecules IC, IU and IP showed similar 
behaviour to that observed soon after transfection. Surprisingly, the ICU construct showed a 33% 
reduction in its activity compared to that detected at 6 h post-transfection. This points to a time-dependent 
inhibitory activity for the CRE element, even in the presence of the translational enhancer 3’UTR. No 
significant changes were detected for the cap-RLuc RNA, showing that the different 3’ tails do not affect 
cap-dependent translation in trans.   
The relative intracellular amounts of the constructs were determined by real time RT-PCR at 6 h and 18 h 
post-transfection to preclude that variations in translation efficiency might be due to differences in RNA 
stability (Fig. 2c). No significant changes in the amount of RNA were detected for different reporter 
molecules, indicating that the 3’ tail modulates IRES translational efficiency without affecting RNA 
stability. 
A new set of variants was generated to further investigate the specificity of the inhibitory effect exerted 
by the CRE element on IRES-dependent protein synthesis. With that aim, the IRES region was exchanged 
for the cap-analogue structure to generate a collection of molecules harbouring the reporter gene fluc 
fused to different 3’ ends (Fig. 3a). Translation efficiency was checked 18 h post-transfection to achieve 
the CRE inhibitory effect. As expected, the presence of the polyA tail and the 3’UTR induced cap-
dependent FLuc protein synthesis [22], confirming the suitability of the experimental model (Fig. 3b). 
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The CRE region alone was unable to affect cap-dependent translation (molecule FC), but it attenuated the 
translational enhancement exerted by the 3’UTR (construct FCU). Taken together, these data support the 
idea that the CRE element alone influences IRES activity without perturbing cap-dependent translation.    
 
IRES-dependent translation is inhibited by the CRE element both in 
hepatic and non-hepatic cells 
We performed the same set of experiments in three additional cell lines, including hepatic (Hep-G2) and 
non-hepatic (HeLa and HEK-293) models, to further study the effects of the cellular environment on the 
activity of the CRE region (Fig. 4).  
Molecules containing either the polyA tail or the 3’UTR stimulated IRES-mediated translation (Fig. 4), in 
good agreement with previous data obtained for the Huh-7 cell line (Fig. 2b). Similarly, the IC construct 
was clearly defective for IRES-mediated translation compared to the molecule RNA I. Again, this 
inhibitory effect was even detected in the presence of the translational enhancer 3’UTR. Interestingly, the 
ICU variant showed a significant reduction in its activity at 18 h post-transfection only in hepatic cells 
Huh-7 and Hep-G2. These results indicate that the CRE region blocks IRES activity on its own, 
independent of the cell type and that the addition of the 3’UTR attenuates this drastic effect in a cell line 
and time-dependent way. This prompted our use of Huh-7 cells as the exclusive model for subsequent 
analysis. 
  
The domain 5BSL3.2 within the CRE region interferes with IRES activity 
The structural elements 5BSL3.1, 5BSL3.2 and 5BSL3.3 were independently deleted from the ICU 
variant with the aim of identifying the essential domains for the inhibitory effect (Fig. 5a). All 
experiments were performed at 18 h post-transfection, the maximum inhibitory effect of the CRE region. 
The deletion of domain 5BSL3.1 or 5BSL3.3 did not report significant differences in IRES translational 
efficiency with respect to construct ICU (Fig. 5b). Interestingly, variants lacking element 5BSL3.2 were 
associated with a five-fold increase in IRES activity compared to that observed for the ICU molecule. A 
double deletion mutant was generated lacking domains 5BSL3.1 and 5BSL3.3 to corroborate the 
influence of the 5BSL3.2 domain on IRES function (Fig. 5a). This RNA molecule showed similar 
translational efficiency to that shown by the single mutants (Fig. 5b). Taken together, these data suggest 
that domain 5BSL3.2 is the main agent responsible for the IRES inhibitory effect induced by the CRE 
region.  
 
The internal loop of domain 5BSL3.2 is required for the regulation of HCV 
IRES function   
Domain 5BSL3.2 consists of different structural elements that interact with distant regions in the HCV 
genome – possibly investing this domain with a regulatory role in essential steps in the viral cycle  [37, 
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45, 46, 50]. A set of reporter constructs was generated to further analyse the involvement of these 
structural constituents in IRES-dependent translation. Mutations in the apical or internal loop were 
included in the ICU variant (Fig. 6a) and the constructs tested for their translational efficiency at 18 h 
post-transfection.  
The molecule harbouring the sequence of the apical loop in reverse orientation had no significant effect 
on IRES-dependent protein synthesis in Huh-7 cells (Fig. 6b). In contrast, the deletion of the internal loop 
promoted a drastic (up to 8-fold) stimulation of IRES activity. These results strongly suggest that the 
internal loop of 5BSL3.2 is the main agent responsible for the regulation of IRES function. Two 
additional variants with different modifications of the internal loop were constructed to investigate this 
possibility (Fig. 6a): ICU-3.2R, with a non-related sequence in the internal loop described to abolish viral 
replication [46], and ICU-3.2m, with three modified residues (CCC to GGG) that impede the interaction 
of 5BSL3.2 with domain IIId of the IRES [37]. Both of these RNA molecules enhanced IRES function by 
up to 7-fold with respect to the ICU molecule (Fig. 6b).  
Taken together, these data suggest a functional role for the internal loop of 5BSL3.2 in IRES-dependent 
translation and support the notion of tertiary contacts between this element and the apical loop of domain 
IIId of the IRES.    
 
DISCUSSION 
It has been shown that mRNA must have a circular conformation if translation is to be efficient. The 
acquisition of this geometry is promoted by the interaction between the termini in capped and polyA 
mRNAs. This structure is conserved by cellular protein factors that act as molecular bridges between the 
ends of mRNA, helping to preserve its physical integrity (for a review see [51]). However, many viral 
RNAs lack cap and/or polyA elements. For the members of the Flavivirus genus, the acquisition of the 
closed loop conformation is promoted by direct RNA-RNA interactions that involve complex high order 
structural regions [52, 53]. In the case of HCV, a closely related virus, we previously demonstrated the 
existence of an interaction  between the specific functional domains IIId and 5BSL3.2 of the two highly 
conserved IRES and CRE regions at opposite ends of the genomic RNA  [37]. Both sites are associated 
with essential functions in viral translation and replication. The present work analyses the impact of the 
interaction IRES-CRE in protein synthesis and demonstrates the implication of domain 5BSL3.2 in IRES-
dependent translation. 
A collection of reporter RNA molecules was generated to investigate the role of the different structural 
elements at the 3’ end of the HCV genome in IRES-dependent translation. The folding of these domains 
in the chimeric constructs was evaluated by secondary structure prediction with the MFold software [54]. 
These in silico analysis showed that the expected conformation of the HCV genomic domains was 
preserved in all the variants tested (data not shown), though we cannot rule out the existence of 
alternative conformations promoted by the cellular environment. The use of monocistronic constructs 
avoids collateral cis-effects derived from the presence of additional regulatory domains [55]. In addition, 
the integrity of the 3’ end, which is critical for the reproducibility of results, was assessed using DNA 
templates obtained by PCR [12, 56]. The time points for assaying the activity of the reporter gene were 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
  9 
taken into account [12]; the IRES reaches its maximum activity soon after transfection, which might be 
important when testing the regulatory effects of the elements under study.  
The results showed that the CRE region promoted a drastic reduction in the efficiency of IRES function 
(Fig. 2). This effect was even detected in the presence of the 3’UTR at 18 h post-transfection, suggesting 
a dual regulatory activity for the CRE region by the attenuation of the 3’UTR translational enhancement 
in a time-dependent way and by directly affecting to IRES activity. This hypothesis is reinforced by the 
observation that the CRE region alone had no effect on cap-dependent protein synthesis, but its inhibitory 
effect over the 3’UTR translational enhancement was still present (Fig. 3). Our results point to a complex 
interplay between the three regions. This is also supported by previous data reporting the existence of a 
kissing apical loop-apical loop interaction between the 5BSL3.2 domain of the CRE and the 3’SLII 
domain of the 3’UTR [46]. It should be noted that the IRES activity results for the construct carrying the 
whole 3’ end of the HCV genome at 18 h post-transfection correlated perfectly with those reported by 
Lourenço et al. [21], who detected no effect of the whole 3’ end over IRES-dependent translation at a 
single time point of 24 h after transfection. The results obtained from the time-course assays at early post-
transfection allowed the detection of the CRE regulatory effect on IRES function. To our knowledge, this 
is the first report describing this phenomenon. Data obtained for the control constructs harbouring the 
3’UTR or a polyA tail were consistent with those reported by other groups [12, 21, 22].  
The inhibitory effect exerted by the CRE did not seem to depend on the cell line. Nevertheless, the 
regulatory activity of the whole 3’ end in the ICU variant is restricted to hepatic cells (Fig. 4). This 
suggests that the interplay between the three regions IRES, CRE and 3’UTR occurs under specific cell 
conditions and likely requires additional factors as well as RNA-RNA interactions. HCV preferentially 
replicates and propagates in hepatocytes [21, 57-60], which suggests that liver cells may supply these 
factors (protein and RNA) essential to the viral cycle. This is in good agreement with previous 
observations that point to rabbit reticulocyte lysate being an inappropriate system for evaluating IRES 
function [12, 21, 22, 26] (data not shown). It is remarkable that Lee et al. [44] found no effect of the CRE 
region on protein synthesis, probably because they used an in vitro system that might not have been able 
to reproduce the results obtained in hepatic cells.     
Mutational analysis of 5BSL3.2 in the CRE region showed that changes in the internal loop resulted in 
the stimulation of IRES activity by up to 8-fold, depending on the construct used (Figs. 5, 6). This region 
is involved in the establishment of a long range RNA-RNA interaction with domain IIId of the IRES [37], 
the key element for the binding of the 40S ribosomal subunit. It seems likely that mutations interrupting 
this contact would favour an increase in ribosome recruitment, thus leading to more efficient IRES 
function. It is also noteworthy that similar modifications lead to deleterious replicating genomes [46, 50]. 
This suggests a dual role for domain 5BSL3.2 in two different events of the viral cycle.  
The effects detected for the CRE and the 3’UTR regions over the IRES activity are assumed to be 
preferentially exerted in cis, though we cannot exclude intermolecular contacts involving both termini of 
the RNA molecules. This hypothesis is supported by previous data demonstrating that the IRES 
translational enhancement mediated by the 3’UTR only operates in cis [18]. Moreover, we have shown 
that the 3’UTR is unable to suppress in trans the translation inhibition effect exerted by the CRE domain 
(unpublished data). In addition, the location of 5BSL3.2 along the transcript could be relevant to play its 
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regulatory action over IRES-dependent translation (Romero-López et al., unpublished results).  These 
observations support the existence of a close loop conformation mediated by a long distant RNA-RNA 
contact between the IRES and the CRE region, which could be preserved by cellular factors bound at the 
5’ and the 3’ ends of the viral genome. The circular form would determine the translation and replication 
of intact HCV RNA molecules and could direct the switch between viral translation and replication. 
In summary, the present data reinforce the idea of a direct RNA-RNA interaction between domain IIId of 
the IRES and 5BSL3.2 in the CRE region previously described by our group [37]. They also support the 
role of the CRE domain as a modulating agent in IRES-dependent translation and point to domain 
5BSL3.2 as a key element in the regulation of viral protein synthesis. It is tempting to propose roles for 
this element in essential steps of the infective cycle and in the switch between viral translation and 
replication.  
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FIGURE LEGENDS 
 
Fig. 1 a) Sequence and secondary structure of the 5’ and the 3’ ends of the HCV genome. The 5’UTR 
plus domains V and VI located in the core coding sequence are included. The 3’ end of the viral genomic 
RNA is organized into two structural elements: the CRE region containing the three stem-loops 5BSL3.1, 
5BSL3.2 and 5BSL3.3; and the 3’X-tail, linked by a hypervariable sequence and the polyU/UC stretch. 
Numbers refer to the nucleotide positions of the HCV Con1 isolate. Start and stop translation codons at 
positions 342 and 9371 respectively are shown in bold. b) Theoretical kissing interaction involving the 
apical loop of domain IIId and the internal loop of 5BSL3.2 
 
Fig. 2 a) Diagram of the IRES reporter constructs. The 3’ end of the HCV genome harbouring the CRE 
region plus the 3’UTR was attached to the IRES-FLuc fusion, as shown above. Harmful mutants for the 
3’ tail are shown below. The IP variant includes an artificial polyA tail at the 3’ end of the sequence. b) 
The 3’ tail influences IRES-dependent translation. Huh-7 cells were co-transfected with the RNA 
molecules indicated in a) and the RNA RLuc. IRES function was measured as the activity of FLuc protein 
and normalized against that obtained for RLuc. Luciferase activity in the variant I is established as 100%. 
Data points are the mean of at least three independent experiments. c) RNA stability control. RNA 
reporter constructs were transfected into Huh-7 cells and total cellular RNA was isolated at the indicated 
times using Trizol reagent. Quantitative RT-PCR was performed with specific primers plus the Taqman 
probe for the HCV IRES or the GAPDH mRNA. The results were analysed using ABI PRISM SDS 
Software 1.1 (Applied Biosystems). * indicates significant differences (p<0.05) between the translational 
efficiency of different constructs. Data are the mean of three independent experiments 
   
Fig. 3 a) Diagram of the cap reporter constructs. Different fragments of the 3’ end of the HCV genome 
were fused to the FLuc coding sequence, which is translated in a cap-dependent way. The FP variant 
harbours at its 3’ end a synthetic polyA tail. b) Molecules shown in a) were co-transfected with the RLuc 
RNA and relative luciferase units were measured at 18 h post-transfection as indicated in Fig. 2b. 
Molecule F was established as providing 100% translation (control). Data are the mean of at least three 
independent experiments 
 
Fig. 4 Effect of the 3’ tail on IRES-dependent translation in different cell lines. Hep-G2, HeLa and HEK-
293 cells were co-transfected with the molecules shown in Fig. 2a and RLuc RNA. They were harvested 
at 6 h and 18 h post-transfection and luciferase activity measured as indicated in Fig. 2b. Data normalized 
against to those obtained for the variant I and represent three independent assays 
 
Fig. 5 a) Deletion mutants of the three stem-loops of the CRE region constructed from the ICU molecule 
(Fig. 2a). b) Variants shown in a) were co-transfected with the RLuc RNA in Huh-7 cells. The 
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translational efficiency of the IRES region was evaluated at 18 h post-transfection as indicated in Fig. 2b. 
The control reaction was set for the ICU construct. Means correspond to four independent experiments 
 
Fig. 6 a) Mutations targeting the apical loop or the internal loop of domain 5BSL3.2. The ICU construct 
(Fig. 2a) was modified at the positions of the 5BSL3.2 domain shown in bold to generate a set of variants. 
The sequence and secondary structure of the wild-type stem-loop is shown above. b) The effects of the 
mutations in 5BSL3.2 were analysed by co-transfection of the molecules shown in a) (above) with the 
cap-RLuc RNA in Huh-7 cells. Relative luciferase activity was quantified at 18 h post-transfection as 
described in Fig. 2b. Values were normalized against those obtained for the ICU construct and represent 
the mean of four independent experiments 
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Table 1 Oligonucleotides used in this study 
 
Oligonucleotide 5’-3’ sequence 
5’T7pHCV TAATACGACTCACTATAGCCAGCCCCCTGATGG 
asHCV-698+HindIII  TATAAGCTTCCAAATTGCGCGACCTAC 
HCV-9181+Xba1  AATTCTAGAGGGCAGTAAGGACCAAGCTCA 
3’HCV+BamH1  TATGGATCCACTTGATCTGCAGAGAGGCCA 
asFLuc TCTAGAATTACACGGCGATCTTTCCGC 
HCV-9383 CTAAACACTCCAGGCCAATAGGCCATC 
HCV-9260  TTACAGCGGGGGAGACATATATCACAG 
asHCV-9215 GATTGGAGTGAGTTTGAGCTTGGTCCT 
HCV-9311  GTTCATGTGGTGCCTACTCCTACTTTCTGTA 
asHCV-9262 TAACCAGCAACGAACCAGCTGGATAAATCCAA 
HCV-9352  TCTATCTACTCCCCAACCGATGAACGG 
asHCV-9320 CCACATGAACCAGCGGGGTCGGGCA 
HCV-9277ALinv CCGACACTATATTGTCTCGTGCCCGACCCCGCTGGT 
asHCV-9276 TGTCTCCCCCGCTGTAACCAGCAACGA 
HCV-9303  CCCCGCTGGTTCATGTGGTGCCTACTCCTACTT 
asHCV-9294 GAGACAGGCTGTGATATATGTCTCCCCCGCTGT 
HCV-9313  CATGTGGTGCCTACTCCTACTTTCT 
HCV-9315 ATGTGGTGCCTACTCCTACTTTCTGTAGGGGTA 
asHCV-3.2mut GAACCAGCGGGGTCCCCGACGAGACAGGCT 
HCV-9352  TCTATCTACTCCCCAACCGATGAACGG 
asHCV-9320 CCACATGAACCAGCGGGGTCGGGCA 
3’HCV ACTTGATCTGCAGAGAGGCCA 
asFLuc-PolyA  (A24)TCTAGAATTACACGGCGATCTTTCCGC 
asHCV-9321 ACCACATGAACCAGCGGG 
T7pFLuc TAATACGACTCACTATAGGGATGGAAGCCAAAAACA 
 
*
 T7 promoter is underlined. Restriction sites are noted in italics. 
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